SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
  
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
Cleary James F JR

(Last) (First) (Middle)
3041 W. PASADENA DR.

(Street)
BOISE ID 83705

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
MWI Veterinary Supply, Inc. [ MWIV ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and CEO
3. Date of Earliest Transaction (Month/Day/Year)
10/18/2012
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.01 per share 210,574 D
Common Stock, par value $0.01 per share 10/18/2012 S (1) 1,908 D $104.7464 (2) 108,928 I See footnote (6)
Common Stock, par value $0.01 per share 10/18/2012 S (1) 722 D $105.6243 (3) 108,206 I See footnote (6)
Common Stock, par value $0.01 per share 10/19/2012 S (1) 6,977 D $102.1708 (4) 101,229 I See footnote (6)
Common Stock, par value $0.01 per share 10/19/2012 S (1) 1,229 D $103.3079 (5) 100,000 I See footnote (6)
Common Stock, par value $0.01 per share 1,895 I See Footnote (7)
Common Stock, par value $0.01 per share 1,895 I See Footnote (8)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by The Rebholtz Descendants' Trust on September 8, 2012.
2. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $104.11 to $105.40, inclusive. Mr. Cleary has provided to MWI Veterinary Supply, Inc. (the "Company") and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $105.25 to $106.22, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
4. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $101.865 to $102.76, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
5. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $103.03 to $103.89, inclusive. Mr. Cleary has provided to the Company and undertakes to provide to any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
6. Held by The Rebholtz Descendants' Trust for the benefit of Mr. Cleary's family and certain other persons. Mr. Cleary expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.
7. Held by Teresa Cleary Children's Trust FBO Barbara Cleary for the benefit of one of Mr. Cleary's children. Mr. Cleary expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.
8. Held by Teresa Cleary Children's Trust FBO Abigail Cleary for the benefit of one of Mr. Cleary's children. Mr. Cleary expressly disclaims beneficial ownership of any shares held by such trust that exceed his pecuniary interest therein.
Remarks:
Ryan Cleverley as attorney-in-fact for James F. Cleary, Jr. 10/22/2012
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.